Skip to Main Content

Paper Details

A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques.
Sci Immunol
5
2022
CCR5, CD4, CD4 T, CD4 T cells, CD8, CD8 T cells, CycP, Envelope-specific IgG, Fc, G1FB, G2S2F, HIV, HIV target cells, HIV-1, IFN-, IgG, SHIV, T helper, TNF-, V1V2 scaffolds, cytotoxic CD8 T cell, envelope-specific IgG, gp120, macaques, negative T, rhesus macaques, vaccine-induced proliferating blood CD4 T cells
Author NameAffiliation
Sailaja GangadharaEmory National Primate Research Center, Emory University
Sailaja GangadharaEmory School of Medicine, Emory University
Tiffany M StylesEmory National Primate Research Center, Emory University
Tiffany M StylesEmory School of Medicine, Emory University
Samantha L BurtonEmory National Primate Research Center, Emory University
Zhaohui S QinRollins School of Public Health, Emory University
Cynthia A DerdeynEmory National Primate Research Center, Emory University
Cynthia A DerdeynEmory University
Cynthia A DerdeynEmory National Primate Research Center, Emory University
Cynthia A DerdeynEmory University
Raghavan VaradarajanIndian Institute of Science
Raghavan Varadarajan
Pamela A KozlowskiLouisiana State University Health Sciences Center
Galit AlterRagon Institute of MGH
Rama Rao AmaraEmory National Primate Research Center, Emory University
Rama Rao AmaraEmory School of Medicine, Emory University
  • 1 - 16

Datasets

Release 1.2